Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.
The Corporate Compliance Officer is responsible for leading, developing, and overseeing the company’s comprehensive corporate compliance program, with a primary focus on internal compliance, trade compliance, reporting requirements, document retention, quality compliance, anti-corruption, data privacy and industry standards in the pharmaceutical/biotech sector. Reporting to the Executive Vice President-General Counsel, this role partners closely with Commercial, Clinical, CMC, Quality, Regulatory, and Operations to ensure all company activities align with applicable laws, regulations, contractual obligations, and ethical standards. The ideal candidate is a seasoned compliance professional with deep pharmaceutical or biotech experience, proven leadership in building and managing compliance programs, with experience in international trade compliance involving Europe and/or Japan (e.g., export controls, sanctions, trade regulations, customs, or cross-border technology transfer).